Delcath Systems, Inc.
Delcath Systems, Inc. (DCTH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · DCTH · as of Jun 9, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Delcath Systems, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
DCTH insider buying and selling by quarter
DCTH insider selling · DCTH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · DCTH ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
DCTH executive sell shares · DCTH board member insider trading · DCTH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 6, 2026 | Pennell Sandra CFO | Purchase | 5,533 | $50K | Form 4 |
| Mar 2, 2026 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director | Purchase | 11,200 | $100K | Form 4 |
| Nov 21, 2025 | Sylvester John Richard Director | Purchase | 4,386 | $39K | Form 4 |
| Nov 11, 2025 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director | Purchase | 11,500 | $98K | Form 4 |
| Jun 12, 2025 | Vukovic Vojo CHIEF MEDICAL OFFICER | Option | 42,000 | $201K | Form 4 |
| Oct 22, 2024 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director | Option | 16,666 | $100K | Form 4 |
| Mar 19, 2024 | Vukovic Vojo CHIEF MEDICAL OFFICER | Award | 26,882 | $100K | Form 4 |
| Mar 19, 2024 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER · Director | Award | 40,323 | $150K | Form 4 |
| Mar 19, 2024 | Pennell Sandra SVP OF FINANCE, PFO AND PAO | Award | 26,881 | $100K | Form 4 |
| Mar 19, 2024 | Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | 13,441 | $50K | Form 4 |
| Mar 19, 2024 | Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | 20,161 | $75K | Form 4 |
| Dec 12, 2023 | Vukovic Vojo Chief Medical Officer | Purchase | 40,000 | $120K | Form 4 |
| Dec 8, 2023 | MICHEL GERARD J CEO · Director | Purchase | 34,000 | $100K | Form 4 |
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 2
Shares
11,200
Price
$8.96
Value
$100K
Sylvester John Richard
Director
Date
Nov 21
Shares
4,386
Price
$8.89
Value
$39K
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER · Director
Date
Nov 11
Shares
11,500
Price
$8.53
Value
$98K
Vukovic Vojo
CHIEF MEDICAL OFFICER
Date
Jun 12
Shares
42,000
Price
$4.78
Value
$201K
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER · Director
Date
Oct 22
Shares
16,666
Price
$6.00
Value
$100K
Vukovic Vojo
CHIEF MEDICAL OFFICER
Date
Mar 19
Shares
26,882
Price
$3.72
Value
$100K
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 19
Shares
40,323
Price
$3.72
Value
$150K
Pennell Sandra
SVP OF FINANCE, PFO AND PAO
Date
Mar 19
Shares
26,881
Price
$3.72
Value
$100K
Muir Kevin
GM INTERVENTIONAL ONCOLOGY
Date
Mar 19
Shares
13,441
Price
$3.72
Value
$50K
Hoffman David L.
GEN'L COUNSEL, CCO & SECY
Date
Mar 19
Shares
20,161
Price
$3.72
Value
$75K
Vukovic Vojo
Chief Medical Officer
Date
Dec 12
Shares
40,000
Price
$3.00
Value
$120K
MICHEL GERARD J
CEO · Director
Date
Dec 8
Shares
34,000
Price
$2.94
Value
$100K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About DCTH insider trading
DCTH insider trades
Delcath Systems, Inc. (DCTH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MICHEL GERARD J (CHIEF EXECUTIVE OFFICER · Director), Pennell Sandra (CFO), Sylvester John Richard (Director). Over the past 12 months, 4 insiders have filed transactions with the SEC. DCTH insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Delcath Systems, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
DCTH insider trading · 5 questionsThe insiders of Delcath Systems, Inc. (DCTH) include executives and directors such as MICHEL GERARD J (CHIEF EXECUTIVE OFFICER · Director), Pennell Sandra (CFO), Sylvester John Richard (Director), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026